공지 • Jun 15
Himalaya Technologies, Inc. announced delayed 10-Q filing On 06/14/2024, Himalaya Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공지 • Mar 15
Himalaya Technologies, Inc. announced delayed 10-Q filing On 03/14/2024, Himalaya Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공지 • Mar 12
Himalaya Technologies, Inc. Appoints David Burns, to Its Advisory Board Himalaya Technologies, Inc. has appointed Renovi!’s CEO, David Burns, Ph.D., to its Advisory Board to guide its entry into this multi-billion dollar market, assist on mergers and acquisitions including a potential combination of Renovi! with Himalaya, and provide management consulting. 공지 • Jan 24
Himalaya Technologies, Inc. Appoints Debbie Wildrick to Advisory Board Himalaya Technologies, Inc. announced that On January 23, 2024, company appointed Debbie Wildrick to Advisory Board to guide and consult on launch of health energy drink under the “FOMO” brand, under notice of allowance for trademark by the USPTO. Ms. Wildrick is a sales, marketing, and operations executive and channel strategy specialist in the consumer packaged goods industry with 30+ years’ experience. She is an executive leader, speaker, and consultant to the food and beverage industries having held several executive positions with early stage brands in the past 15 years. Ms. Wildrick has been instrumental in beverage product development and the supplements and ingredient industries for the last 5+ years. She has had several leadership roles at Fortune 500 companies including 7-Eleven, Inc., where she ran a $4 billion beverage business, and Tropicana North America (PepsiCo), which generates an estimated $3 billion in anual revenue. Ms. Wildrick is a member and a Board Member of ten years of the Network of Executive Women. 공지 • Jan 18
Himalaya Technologies Prepares Launch of FOMO Token, FOMO Health Drink, FOMO Leisure Line Himalaya Technologies, Inc. announced it has begun the development of the long anticipated FOMO Token. The new ERC20 token will be the cornerstone swap utility for a FOMO decentralized ecosystem and will power dapps and other blockchain technologies for the tokenization of real world assets. The company, along with its affiliate FOMO WORLDWIDE, INC. plans to announce incentives and special rewards for FOMO shareholders to become FOMO Token holders, including potential future dividends and/or OTC share swaps to derive value from the blockchain. 공지 • Nov 19
Himalaya Technologies, Inc. has filed a Follow-on Equity Offering in the amount of $0.3 million. Himalaya Technologies, Inc. has filed a Follow-on Equity Offering in the amount of $0.3 million.
Security Name: Common Shares
Security Type: Common Stock
Securities Offered: 300,000,000
Price\Range: $0.001
Discount Per Security: $0 공지 • Jun 15
Himalaya Technologies, Inc. announced delayed 10-Q filing On 06/14/2023, Himalaya Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공지 • May 05
An unknown buyer acquired Oil and gas wells from Himalaya Technologies, Inc. (OTCPK:HMLA). An unknown buyer acquired Oil and gas wells from Himalaya Technologies, Inc. (OTCPK:HMLA) in 2022.An unknown buyer completed the acquisition of Oil and gas wells from Himalaya Technologies, Inc. (OTCPK:HMLA) in 2022. 공지 • Feb 07
Himalaya Technologies, Inc., Annual General Meeting, Mar 17, 2023 Himalaya Technologies, Inc., Annual General Meeting, Mar 17, 2023, at 14:00 US Eastern Standard Time. Location: 831 W North Ave. Pittsburgh Pennsylvania United States 공지 • Nov 03
Himalaya Technologies, Inc. (OTCPK:HMLA) signed a purchase agreement to acquire assets of a training software provider based in the Midwest for $0.28 million. Himalaya Technologies, Inc. (OTCPK:HMLA) signed a purchase agreement to acquire assets of a training software provider based in the Midwest for $0.28 million on October 28, 2022. The consideration includes $0.12 million cash due on closing by November 30, 2022, subject to extension, promissory notes of $0.07 million due January 1, 2023 and $0.04 million due January 1, 2024, and a $0.05 million performance based earnout. 공지 • Nov 01
Himalaya Technologies, Inc. announced delayed annual 10-K filing On 10/31/2022, Himalaya Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. 공지 • Jun 16
Himalaya Technologies, Inc. announced delayed 10-Q filing On 06/15/2022, Himalaya Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공지 • Jan 12
Himalaya Technologies, Inc. Launches Kanab Club Out of Open Beta Himalaya Technologies, Inc. has launched its wholly owned cannabis social network “Kanab Club” out of open beta. After several months of closed and open testing, the site has been proven to be stable and scalable and is now ready to layer on additional functionality. The business’ programmers have completed an invite engine for subscriber contacts, a friend recommendation engine, messaging functionality, public and private feeds, a general chat forum interconnecting with Discord, and third-party interconnections including Weedmaps. Going forward, management is budgeting development of a stock chat room, blogging, 420 dating, e-commerce, and iOS and Android apps, much of which is targeted for completion in phases by the end of 2022. These and other potential future modules and features are being designed to drive traffic to the site. The Company is also in discussions with strategic partners in the B2C and B2B space to further differentiate the site and add scope and scale to set the stage for future monetization. 공지 • Sep 21
Himalaya Technologies, Inc. (OTCPK:HMLA) agreed to acquire OTC.WATCH LLC and 19.99% of GenBio Inc. Himalaya Technologies, Inc. (OTCPK:HMLA) agreed to acquire OTC.WATCH LLC and 19.99% of GenBio Inc on September 20, 2021. Terms agreed to include the issuance of Series B preferred shares convertible into 20% of the fully diluted shares of HMLA, or roughly 84,000 Series B preferred shares for OTC.WATCH and GenBio. Due diligence and paperwork are underway.